Research & Development
Pathology & AI
Use of adapted D-dimer thresholds rules out PE in high-risk patients
But instead of using different strategies on different patients, hospitals should standardize one strategy for their institution's use to gain the most benefit, wrote Dr. Frederikus Klok, PhD, of the Leiden University Medical Center in the Netherlands, and colleagues. The researchers also indicated that using such tests would reduce the need for clinical imaging.
December 15, 2021
Fujifilm companies merge, executive team named
Fujifilm noted that its combined healthcare portfolio spans a variety of medical imaging modalities, and the company is working on artificial intelligence initiatives for imaging services.
October 3, 2021
Xifin buys Computerized Management Services
Xifin already has a strong market position in the laboratory billing space, and the Computerized Management Services deal now gives the firm a footprint in medical imaging, according to the company. Xifin sees parallels between both spaces, with both lab and imaging providers forced to deal with growing caseloads while at the same time managing lower reimbursement, client fee reductions, and challenges in claims processing.
July 6, 2021
Fujifilm doubles down on healthcare in $11B strategic plan
Fujifilm on April 15 launched its new Vision2023 strategic plan that guides the spending of $11 billion over the next three years. The plan is designed to accelerate growth in the healthcare sector, as well as in the company's highly functional materials business segment, which produces films for liquid crystal displays (LCDs).
April 15, 2021
5 reasons lab professionals should get up to speed on Twitter
Twitter has become a crucial social media hub for doctors and other healthcare professionals, as well as for media professionals following and publicizing medical research.#CAPVirtualPath has more than 9 million impressions! Bravo to @Pathologists and all the people making this possible. I love the composite image. #WeAreNotAlone#ILookLikeAPathologist pic.twitter.com/dtu2bxPx8Y
March 29, 2021
Researchers get $3.3M to study AI in oral cancer
The U.S. National Cancer Institute awarded the five-year grant to a group led by Anant Madabhushi, PhD, the Donnell Institute Professor of Biomedical Engineering at CWRU and head of the Center for Computational Imaging and Personalized Diagnostics, and Dr. James Lewis Jr., a pathology, microbiology, and immunology professor at Vanderbilt University Medical Center.
January 5, 2021
DNA forensic evidence frees Ohio man of rape, attempted rape
Chembio Diagnostics applies for FDA CLIA waiver for HIV, syphilis test
Dr. Fauci invokes Yogi Berra to describe emerging infectious disease challenge
AnchorDx enrolling U.S. clinical trial for bladder cancer assay
Thermo Fisher Scientific updates Applied Biosystems genetic analyzers to comply with IVDR
Week in Review: Elizabeth Holmes sentenced; good cholesterol worse for some adults; earlier type 2 diabetes diagnosis; and more
U.K. increases funding for AI to diagnose disease
The centers of excellence were launched in 2018 with the goal of using AI to improve the diagnosis of disease. Three centers in London, Leeds, and Coventry will receive a share of the new funds to deliver digital upgrades to pathology and imaging services across 38 National Health Service trusts, benefitting 26.5 million patients across England, according to the Department of Health and Social Care.
September 1, 2020
Ibex highlights clinical study results
The study used the software to analyze slide images of prostate core needle biopsies. It was conducted by Dr. Liron Pantanowitz and Dr. Rajiv Dhir of the University of Pittsburgh Medical Center.
July 27, 2020
Imagia, Illumina partner to advance precision medicine
The collaboration is aimed at investigating precision medicine to decipher information on patient-specific biology. Real world patient data will be organized to better understand disease evolutions and improve patient outcomes with new management tools, particularly in the areas of genomic data analysis and artificial intelligence (AI) biomarker discovery.
June 22, 2020
Terahertz spectroscopy opens options in COVID-19 screening
Currently, there is a focus on developing antibody tests, for instance, which could also determine whether a patient had previously been infected, helping epidemiologists better understand the spread of the disease in a population. However, other researchers are thinking far outside the typical box of life science tools; some have turned to terahertz spectroscopy as a potential boon to COVID-19 detection.
June 22, 2020
Shared systems enable digital pathology deployments: Part 1
In radiology and cardiology, enterprise imaging systems (EIS), better known as PACS, have transformed the way studies are interpreted, stored, and shared. The same can be said for electronic medical record (EMR) systems that allow data to be mined and assist in patient diagnoses. Having access to all clinical data is especially crucial as artificial intelligence (AI) systems are starting to play a larger role in the radiology interpretation process. Yet digital pathology systems (DPS) seem to lag behind in terms of adoption.
February 19, 2020
Page 1 of 1